Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 11/20 | 0.50 |
| ▸ | MTNR1B | P49286 | 11/20 | 0.50 |
| ▸ | PLG | P00747 | 1/20 | 0.43 |
| ▸ | PLAU | P00749 | 1/20 | 0.43 |
| ▸ | PLAT | P00750 | 1/20 | 0.43 |
| ▸ | KLK1 | P06870 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 2/20 | 0.41 |
| ▸ | HTR2C | P28335 | 2/20 | 0.41 |
| ▸ | HTR2B | P41595 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9019865 | 1.00 | MTNR1A (0.50) | MTNR1AMTNR1BPLGPLAUPLAT | |
| SCHEMBL8088925 | 0.88 | HTR2A (0.55) | MTNR1AMTNR1BHTR2AHTR2CHTR2B | |
| SCHEMBL8089150 | 0.88 | HTR2A (0.55) | MTNR1AMTNR1BHTR2AHTR2CHTR2B | |
| SCHEMBL8102619 | 0.87 | MTNR1A (0.48) | MTNR1AMTNR1BHTR2AHTR2CHTR2B | |
| SCHEMBL8088846 | 0.84 | FFAR1 (0.48) | MTNR1AMTNR1BHTR2AHTR2CHTR2B | |
| SCHEMBL8088849 | 0.84 | FFAR1 (0.48) | MTNR1AMTNR1BHTR2AHTR2CHTR2B | |
| SCHEMBL8101325 | 0.84 | MTNR1A (0.45) | MTNR1AMTNR1BFFAR1 | |
| SCHEMBL8101326 | 0.84 | MTNR1A (0.45) | MTNR1AMTNR1BFFAR1 | |
| SCHEMBL8104774 | 0.84 | CNR2 (0.48) | MTNR1AMTNR1B | |
| SCHEMBL8104776 | 0.84 | CNR2 (0.48) | MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0747346-A2 | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-11 | — | — | EP | disclosed |